A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

Clinical trial NCT07577479 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07577479
Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Study

Start date: 2026-05-18
Primary completion: 2027-06-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.